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Adipose tissue is classically viewed as an energy 
depot in any standard biomedical textbook. In recent 
decades, however, adipose tissue has gradually been 
transformed into a bona fide endocrine tissue. The 
strongest evidence comes from the discovery of 
the first fat hormone or adipocytokine, leptin.1 
Leptin is the product of ob gene, and is mainly ex-
pressed in adipose tissue and secreted into sys-
temic circulation. Leptin has been shown to be a 
major regulatory hormone of appetite by acting on 
the hypothalamus via a negative feedback loop. 
Humans with leptin deficiency that results from 
genetic mutations would rapidly develop early-on-
set severe obesity primarily due to unsuppressed 
appetite, although they have normal weight at 
birth.1,2 However, this is a rare condition with few 
case reports world-wide.2 In contrast to the absence 
of leptin in the previous condition, subjects with 
common obesity have elevated blood leptin levels, 
suggesting a leptin-resistant state.1 In general, blood 
leptin levels reflect generalized body adiposity.1 
Leptin is also found to be related to other physio-
logical or pathological conditions beyond appetite 
control and obesity. These include the roles of leptin 
in pregnancy and fetal growth, which are the most 
interesting for pediatricians and obstetricians.3
In this issue of the journal, Tung et al4 explored 
the relationship between umbilical cord blood leptin 
levels and birth weight of full-term neonates. The 
authors used a somewhat large sample size with 
the inclusion of only full-term babies and no pre-
term neonates. Consistent with previous reports, 
they found that the cord blood leptin levels were 
higher in babies that are large and appropriate for 
gestational age than those that are small for gesta-
tional age. This may be explained by higher adipos-
ity in babies with higher birth weight. Since fetal 
nutrient intake during pregnancy is not regulated 
by fetal appetite, and individuals with leptin defi-
ciency have normal birth weight, the significance of 
higher cord blood leptin levels may not be extended 
beyond the simple reflection that babies large and 
appropriate for gestational age have higher adiposity 
when compared to those small for gestational age. 
Nevertheless, any proposed biological effects, sub-
tle or prominent, on pregnancy and fetal growth in 
humans merit further investigation.3
In addition to leptin, another adipocytokine, 
adiponectin has also been reported to have signifi-
cant biological and medical implications.5,6 In adults, 
for instance, plasma adiponectin is inversely asso-
ciated with adiposity.6 It has been suggested that 
plasma adiponectin is not a regulator of body weight, 
but rather, a mediator of the metabolic effects of 
altered adiposity.5 The umbilical cord blood adi-
ponectin levels appear to be higher in fetus than 
the plasma levels in adults, and have been found to 
be positively associated with birth weight and fat 
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mass.7,8 Although Tung et al did not investigate cord 
blood adiponectin levels in this issue, a recent study7 
examined the levels of both cord blood leptin and 
adiponectin, and their relation to infant develop-
ment in the initial 6 months and at 3 years of age. 
The study reported that lower cord blood levels of 
both leptin and adiponectin were significant posi-
tive predictors for weight gain in early childhood.7 
The differences in the relationships between leptin/
adiponectin and body weight at different develop-
mental stages highlight the importance of further 
investigation into the biological and clinical impli-
cations of leptin and adiponectin on fetal develop-
ment. Beyond leptin and adiponectin, there are many 
more similar hormones on the waiting list (e.g., 
visfatin and omentin) whose function and clinical 
significance remain to be fully characterized. This 
uncharted territory in the relationship between 
adipocytokines in neonatal umbilical cord blood 
and fetal growth and development remains to be 
claimed by any interested and devoted pediatri-
cian and obstetrician.
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